Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
The latest update is out from I3 Verticals ( (IIIV) ).
On May 5, 2025, i3 Verticals, LLC, a subsidiary of i3 Verticals, Inc., completed the sale of its healthcare revenue cycle management business to Infinx, Inc. for $96 million in cash. This divestiture allows i3 Verticals to focus on its core operations in the Public Sector, particularly in the K-12 education market, while Infinx enhances its AI-driven solutions with the acquired expertise and technology.
Spark’s Take on IIIV Stock
According to Spark, TipRanks’ AI Analyst, IIIV is a Outperform.
I3 Verticals’ overall stock score reflects strong financial performance, particularly in profitability and cost management, coupled with a robust earnings call that highlights revenue and EBITDA growth. The technical indicators point to moderate upward momentum, though potential overbought conditions warrant caution. The low P/E ratio suggests the stock might be undervalued, offering a compelling investment opportunity. Overall, while revenue growth challenges and overbought technical conditions present risks, the company’s strategic focus and financial health position it well for future growth.
To see Spark’s full report on IIIV stock, click here.
More about I3 Verticals
i3 Verticals, Inc. is a company that delivers seamless enterprise software to customers in strategic vertical markets, focusing on public and private organizations in the Public Sector, including K-12 public education.
Average Trading Volume: 216,819
Technical Sentiment Signal: Strong Buy
Current Market Cap: $849.1M
See more insights into IIIV stock on TipRanks’ Stock Analysis page.